Leitlinienprogramm OnkologiePrevention of Skin Cancer

13. Tabellenverzeichnis – Prevention of Skin Cancer

Version 2.1 · August 2021 · AWMF 032/052OL
Leitlinienprogramm Onkologie · Deutsche Krebsgesellschaft · Deutsche Krebshilfe · AWMF

T category of skin cancer

N Category of skin cancer

M Category of skin cancer

Clinical stages of skin cancer

T category of primary tumor in malignant melanoma (2018).

N category of regional lymph nodes in malignant melanoma (2018).

M category of distant metastases in malignant melanoma (2018).

Staging of malignant melanoma (2018).

Current key figures for malignant melanoma in Germany

Current key figures for non-melanocytic skin tumours in Germany

Age-standardized incidence rates of malignant melanoma

Skin types (Law on Protection against Non-Ionizing Radiation) ("Ordinance on Protection against Harmful Effects of Artificial Ultraviolet Radiation (UV Protection Ordinance - UVSV)," 2011).

Relative risks for malignant melanoma (MM)

Influence of the UV exposure pattern on the relative risk for melanoma development

Skin type as a risk factor of non-melanocytic skin cancer

Exemplary constitutional risk factors of malignant melanoma

Study results on the relationship between sunbed use and skin cancer risk

Summary of possible health impacts of changes in stratospheric ozone (via changes in UV radiation) and due to climate change, and possible interactions. Red arrows show possible impacts of climate change on UV-related health effects.

Summary of possible health impacts of changes in stratospheric ozone (via changes in UV radiation) and due to climate change, and possible interactions. Blue arrows show possible effects of UV radiation on climate change-related health risks.

Overview of the information that can be derived from these studies regarding the weather parameters that control leisure behaviour and the behavioural patterns that have been identified.

Number of outdoor workers by discipline (Federal Employment Agency, 2019)

Occupationally acquired UV radiation exposure of selected disciplines

Screening in the context of early cancer diagnoses

Potential harms and benefits of screening

Informed Decision Algorithm

Effect measures and calculation tool of preventive measures

Dokumentation der Änderungen von Version 1.2 zu Version 2.1